期刊文献+

我国人体试验知情同意之立法完善 被引量:1

The Legislative Improvement on Informed Consent of Human Subject Research
在线阅读 下载PDF
导出
摘要 知情同意是人体试验的关键问题,对于受试者利益的保护具有重要意义。在规范人体试验时,我国法律对知情同意有相关规定,但存在一定的缺失和不足。在研究者告知义务方面,对于研究者的说明事项规范有待改进。在受试者同意方面,将行为能力制度运用于受试者的同意能力不适当,有建立"医事上同意能力制度"的必要,且受试者的同意能力应当依据个案判断。知情同意实践中,弱势群体之一孕妇参与人体试验在我国存在立法缺失,应予以补充和完善。 Informed consent is critical to the human subject research and has great significance to human subject's interest.Although there are some relevant legal regulations about informed consent,some defects and inadequacies still exist.As to the investigator's obligation to notify,instructions and specifications still need improving.As to the subject's consent,it is inappropriate to identify his capacity with hais consent.Therefore,it is necessary to establish a system of subjects' consent in medical institutions and judge subjects' consent through case study.In practice,pregnant women as one of the vulnerable groups,their participating in the human subject research leaves legislative deficiency which should be supplemented and perfected.
作者 何霞
出处 《安徽广播电视大学学报》 2010年第4期31-35,共5页 Journal of Anhui Radio & TV University
关键词 人体试验 知情同意 告知义务 human subject research informed consent obligation to notity
  • 相关文献

参考文献6

二级参考文献20

  • 1徐冰川、马宁等:《紧急叫停哈佛在华实验》,《羊城晚报》2002年4月5日.
  • 2P. Dalla-Vorgia, J. Lascaratos, P. Skiadas, T. Garanis-Papadatos, "Is Consent in Medicine a Concept only of Modem Times?" Journal of Medical Ethics, Feb. 2001, Vol. 27, Issuel, P. 59.
  • 3Ronald Munson, Intervention and Reflection: Basic Issues in Medical Ethics, [ M ] Belmont: Wadsworth/Thomson Leaming, 1999, P. 474; P. 476-491.
  • 4Wolfe & Suzanne, "How Informed Consent Should Be?" [J] RN , Jun. 2000, Vol. 63, Issue6, P. 77.
  • 5C. Lavelle- Jones et al., "Factors Affecting Quality of Informed Consent", BMJ. 1993 May 8; 306(6887): 1273.
  • 6Christie & Bryan, "AIDS Expert Challenges Ethical Stance on Drug Trials", [J] BMJ,British Medical Journal, 9/8/2001, Vol. 323, Issue7312, P. 531.
  • 7S. J. Edwards, et al. , "Informed Consent for Clinical Trials: in Search of the ‘Best' Method", Sci. Med. ,1998 Dec., 47 (11): 1825-1840.
  • 8L. R.邱吉尔.《美国医学伦理学的发展》[J].医学与哲学,1986,.
  • 9王俊杰,曹莉萍,王旭荣,陈瑞珍,林振强.民事行为能力两分法的讨论[A]中国法医学会司法精神病学专业委员会第一次全国司法精神病学学术会议论文汇编,2002.
  • 10肇晖,邵蓉.关于上市后药品再评价立法的思考[J].上海医药,2008,29(3):116-118. 被引量:2

共引文献30

同被引文献17

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部